Literature DB >> 15808544

Functional significance of the 77C --> G polymorphism in the human CD45 gene: enhanced T-cell reactivity by variantly expressed CD45RA isoforms.

H-T Do1, W Baars, R Schwinzer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15808544     DOI： 10.1016/j.transproceed.2005.01.075

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

1.  CD45 negatively regulates tumour necrosis factor and interleukin-6 production in dendritic cells.

Authors:  Jenny Piercy; Svetla Petrova; Elma Z Tchilian; Peter C L Beverley
Journal:  Immunology       Date:  2006-06       Impact factor: 7.397

2.  Altered CD45 expression in C77G carriers influences immune function and outcome of hepatitis C infection.

Authors:  R Dawes; B Hennig; W Irving; S Petrova; S Boxall; V Ward; D Wallace; D C Macallan; M Thursz; A Hill; W Bodmer; P C L Beverley; E Z Tchilian
Journal:  J Med Genet       Date:  2006-02-27       Impact factor: 6.318

3.  Unusual case presentations associated with the CD45 C77G polymorphism.

Authors:  E Z Tchilian; J Gil; M L Navarro; E Fernandez-Cruz; H Chapel; S Misbah; B Ferry; H Renz; R Schwinzer; P C L Beverley
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

4.  Geographical distribution and disease associations of the CD45 exon 6 138G variant.

Authors:  Victoria Ward; Branwen J Hennig; Kouzo Hirai; Hideki Tahara; Akihiro Tamori; Ritu Dawes; Mineki Saito; Charles Bangham; Henry Stephens; Anne E Goldfeld; Warunee Kunachiwa; Nipapan Leetrakool; Julian Hopkin; Sarah Dunstan; Adrian Hill; Walter Bodmer; Peter C L Beverley; Elma Z Tchilian
Journal:  Immunogenetics       Date:  2006-03-15       Impact factor: 2.846

5.  Altered CD45 isoform expression in C77G carriers influences cytokine responsiveness and adhesion properties of T cells.

Authors:  A Windhagen; D Sönmez; H T Hornig-Do; A Kalinowsky; R Schwinzer
Journal:  Clin Exp Immunol       Date:  2007-09-28       Impact factor: 4.330
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.